PAGB: Labour Must Prioritize Self-Care In First 100 Days Of New UK Government

The UK's consumer healthcare industry association, PAGB, sets out six priorities for the new UK government, following the landslide victory of the Labour Party in the recent general election. One of these priorities is driving Rx-to-OTC switch - something that the UK public also wants, according to the association's latest Self-Care Census, published to mark International Self-Care Day 2024.

UK prime minister Keir Starmer • Source: Shutterstock

The UK consumer healthcare industry association, PAGB, has called on the country’s new government to put self-care at the front of its legislative agenda for the next few months.

“With the UK’s National Health Service under unprecedented pressure – including continued difficulties in accessing a GP appointment, persistent waiting lists and ambulances queuing outside accident and emergency (A&E) – the public’s concern for addressing issues in the NHS are at an all-time high,” PAGB commented in a recently-published action plan.

Prioritizing “deliverable actions on self-care” – especially in the first 100 days since the UK Labour Party won the 4 July general election with a significant, 174-seat majority – could deliver “quick and cost-effective wins” for the new government and “help reduce the burden on the front door of the NHS ahead of the winter illnesses season,” the association added.

Among the six “key actions” recommended by PAGB is leveraging Rx-to-OTC switch to “promote an attractive environment for the OTC sector, to ensure its continued investment in, and prioritization of, the UK market.”

The Labour Party could, for example, draw on the findings of a PAGB-led collaboration with the UK’s Department of Health and Social Care (DHSC) and Medicines and Healthcare products Regulatory Agency (MHRA) and self-care industry on widening patient access to OTC medicines through switching, it suggested. (Also see "UK Government Wants To Work With Industry To Identify OTC Switch Candidates" - HBW Insight, 6 June, 2023.)

Making more drugs available without a prescription could save the UK NHS an estimated additional £1.4bn ($1.8bn) per year, according to research commissioned by PAGB from analysts Frontier Economics. (Also see "Switch More Drugs To Save UK Health System £1.4bn Annually, Says PAGB" - HBW Insight, 25 July, 2023.)

Open Door?

PAGB could be pushing at an open door. Labour’s election manifesto promised to change the emphasis of UK healthcare policy towards prevention, focusing on the management of chronic, long-term conditions.

“Labour’s reforms will shift our NHS away from a model geared towards late diagnosis and treatment, to a model where more services are delivered in local communities,” the manifesto states. “We will embed a greater focus on prevention throughout the entire healthcare system and supporting services. As we knew in 1945, much avoidable ill health can be prevented.”

In his 17 July King's Speech – which outlines the legislative program for the next parliamentary session on behalf of the UK Prime Minister – King Charles III said that the new government “will focus on prevention and improve mental health provision for young people.”

While a legislative instrument was mooted for the latter – the Mental Health Bill – the former promise is not supported by a Bill at this stage.

Public Support

The UK public also wants widened access to medicines, according the PAGB’s latest Self-Care Census, published to coincide with International Self-Care Day (24 July).

Three-quarters (74%) of respondents to PAGB’s survey said they want to see more medicines switched from prescription-only so they can be provided by a pharmacist.

“Increasing switching of prescription-only medicines to pharmacy medicines not only improves people’s choice and access to their treatment, but it can also benefit the healthcare system more broadly,” commented PAGB CEO Michelle Riddalls. “Greater availability of over-the-counter medicines means fewer GP visits, A&E interactions and the potential to prevent self-treatable conditions worsening with early intervention through self-care.”

PAGB also found that almost a quarter (23%) of those aged 25 to 34 in the UK admit they would try to get a doctor’s appointment for a self-treatable condition, compared to just 9% of those aged 65 or older.

“This automatic pilot reliance on primary care, particularly among younger consumers, is worrying and it shows there is still a lot of work to be done around educating consumers on the benefits of self-care,” Riddalls noted. “Utilizing the advice and expertise available from community pharmacies, as well as the wealth of online support and guidance from the NHS and consumer healthcare brands, not only enables consumers to take more control of their health and wellbeing, it also relieves pressure on the health service.” 

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from United Kingdom

Perrigo Adds High-Strength Paracetamol To UK Solpadeine Line

 
• By 

Perrigo aims its new SolpaOne high-strength paracetamol effervescent at UK pharmacists, who now have expanded powers as part of the UK government's Pharmacy First initiative. 

Can Creatine Supplementation Improve Cognitive Function? No, Says UK Health Claims Committee

 
• By 

Germany's Alzchem failed to convince the UK's health claims committee that daily creatine supplementation can contribute to improved cognitive function. 

People On The Move At Galenica, Haleon, Alliance Pharma

 
• By 

A round-up of the latest moves in Europe's consumer health industry: Galenica names head of new Products & Home Care business unit; Haleon appoints general counsel; Alliance Pharma eliminates COO role.

Infographic: Mental Health, Menopause And Weight Loss Ads Targeted By ASA's AI Monitoring System

 
• By 

Consumer health, particularly food supplements that make unauthorized medical or health claims, has been a key area of focus for the UK Advertising Standards Authority's recently introduced Active Ad Monitoring system, which captures ads by relevant advertisers from a range of social media platforms, and applies machine learning algorithms to identify and flag likely non-compliant ads, which are then sent to experts to review and act on. This infographic highlights recent ASA rulings against ads for supplements claiming to treat anxiety and stress, menopause, autism/ADHD and weight loss, which were flagged by AI.

More from Europe

Navamedic Benefits From Eroxon Launch In Nordics

 
• By 

OTC erectile dysfunction treatment Eroxon has made it to the Nordics through local distributor Navamedic, which has reported strong consumer uptake.

People On The Move: Appointments At Nestlé, Ascendis Health, Be-sup

 
• By 

A round-up of the latest global health and wellness moves: Nestlé and Dr Reddy's name JV head; Be-sup hires comms and regulatory director; Ascendis Health appoints interim CFO.

Perrigo’s Consumer Health Brand Talk Gets An Executive Voice With First Brand Chief Appointed

 

David Ball moves from Bayer’s North America business to be Perrigo’s first chief brand and digital officer. He joins CEO who also moved to Perrigo from Bayer with decades of branded product experience.